Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Asahi Kasei presents new beta3-adrenoceptor agonists in recent patent

June 2, 2003

Cellegy appoints Neopharm to distribute Tostrex in Israel

May 30, 2003

Generex schedules Canadian phase IIb trials of Oralin

May 30, 2003

New PTP inhibitors prepared and tested at Applied Research Systems

May 30, 2003

Livial studied for use in breast cancer patients

May 29, 2003

Novel GSK-3beta inhibitors in early development at Janssen

May 29, 2003

Heterocyclic antiobesity agents in early development at Bayer

May 28, 2003

Novel DPP-IV inhibitors in early development at Roche

May 27, 2003

GSK claims orexin receptor antagonists for obesity, sleep disorders and stroke

May 27, 2003

Biovitrum and GSK to focus efforts on highly selective 5-HT2C receptor agonists

May 26, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...